GlassScriptPhysician profile
Riya B Luhar
NPI 1235665662
$8,891.83
in general payments reported to CMS, 2019-2025
40 companies · $3,342 in 2025
The $3,342 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $796 · 2023: $2,430 · 2024: $2,102 · 2025: $3,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,848 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,847.52 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,521.60 | 2021-2025 | |
| Ucb, INC. | $1,028.66 | 2023-2025 | Briviact, Fintepla, Nayzilam |
| Lilly USA, LLC | $904.75 | 2022-2025 | Emgality, Reyvow, Kisunla |
| Lundbeck LLC | $744.82 | 2023-2025 | Vyepti |
| Pfizer INC. | $744.60 | 2023-2025 | |
| Eisai INC. | $470.43 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $444.36 | 2022-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Neurelis, INC. | $278.70 | 2022-2025 | Valtoco |
| Argenx US, INC. | $198.22 | 2024-2025 | Vyvgart Hytrulo |
| Biohaven Pharmaceutical Holding Company LTD. | $127.00 | 2022 | |
| Allergan, INC. | $119.00 | 2021-2022 | |
| Sk Life Science, INC. | $114.58 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $107.21 | 2025 | Nuplazid |
| Biogen, INC. | $105.37 | 2023-2025 | Vumerity, Tysabri, Leqembi |
| Otsuka America Pharmaceutical, INC. | $101.39 | 2023-2024 | Nuedexta |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $89.89 | 2023 | Trudhesa |
| Axsome Therapeutics, INC. | $75.00 | 2025 | Symbravo |
| Impel Pharmaceuticals LLC | $57.05 | 2024-2025 | Trudhesa |
| Ge Healthcare | $54.03 | 2024 | |
| Grifols USA, LLC | $52.51 | 2024-2025 | Gamunex-C |
| Upsher-Smith Laboratories LLC | $49.54 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $40.02 | 2023-2024 | |
| Tonix Medicines, INC. | $38.86 | 2025 | Zembrace Symtouch |
| Neuropace, INC. | $37.89 | 2024 | |
| Neurocrine Biosciences, INC. | $35.60 | 2025 | |
| Merz Pharmaceuticals, LLC | $32.96 | 2025 | Xeomin |
| Janssen Biotech, INC. | $32.53 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.64 | 2025 | Hyqvia |
| Microtransponder, INC. | $28.71 | 2025 | |
| Emd Serono, INC. | $24.82 | 2024 | |
| Csl Behring | $24.78 | 2025 | Hizentra |
| Bio Products Laboratory USA, INC. | $23.89 | 2023 | Gammaplex, Coagadex |
| Alexion Pharmaceuticals, INC. | $23.78 | 2025 | Ultomiris |
| Genentech USA, INC. | $21.96 | 2023 | Ocrevus |
| Scilex Pharmaceuticals INC. | $20.79 | 2023 | Ztlido |
| Itamar Medical INC | $19.88 | 2024 | Watchpatone |
| Livanova USA, INC. | $16.75 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Amneal Pharmaceuticals LLC | $16.75 | 2025 | Crexont |
| Janssen Pharmaceuticals, INC | $16.40 | 2023 | Xarelto |
| Amgen INC. | $15.11 | 2023 | Aimovig |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riya Luhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.